摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7,8,9,10-Tetrahydro-6H-azepino<1,2-a>indole | 17691-64-4

中文名称
——
中文别名
——
英文名称
7,8,9,10-Tetrahydro-6H-azepino<1,2-a>indole
英文别名
7,8,9,10-tetrahydro-6H-azepino[1,2-a]indole;1,2-Pentanoindol
7,8,9,10-Tetrahydro-6H-azepino<1,2-a>indole化学式
CAS
17691-64-4
化学式
C13H15N
mdl
——
分子量
185.269
InChiKey
NODBBPZTSCTAJT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    87 °C(Solv: ethanol (64-17-5))
  • 沸点:
    346.8±11.0 °C(Predicted)
  • 密度:
    1.10±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    4.9
  • 氢给体数:
    0
  • 氢受体数:
    0

SDS

SDS:d112b71c217380917e5fae644ef6cf55
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    7,8,9,10-Tetrahydro-6H-azepino<1,2-a>indole盐酸正丁基锂三乙胺 作用下, 以 四氢呋喃正己烷二氯甲烷 为溶剂, 反应 2.0h, 生成 2-<(S)-1-azabicyclo<2.2.2>oct-3-yl>-1,2,4,5,6,7-hexahydro-2,7a-diazacycloheptafluoren-1-one
    参考文献:
    名称:
    2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists
    摘要:
    Several series of N-(quinuclidin-3-yl)aryl and heteroaryl-fused pyridones were synthesized and evaluated for 5-HT3 receptor affinity. In the heteroaryl series, 2-(quinuclidin-3-yl)tetrahydropyrido-[4,3-b]indol-1-one (8a) and the 4,5-alkano-bridged analogues (14 and 15) displayed high 5-HT3 receptor affinity with pK(i) values > 9. The (3S)-quinuclidinyl isomers had > 10 fold higher affinity than the (3R)-isomers. In a series of 2-quinuclidin-3-yl)isoquinolin-1-ones, derivatives substituted with small lipophilic groups (25b-e) and with 4,5-alkano-bridges (34-36) also displayed high affinity. In particular, the hexahydro-1H-benz[de]isoquinolinone (S,S)-37 was the highest affinity 5-HT3 receptor ligand prepared (pK(i) 10.4). A number of the high affinity ligands were shown to be potent 5-HT3 receptor antagonists in vivo as determined by inhibition of the B-J reflex in the anesthetized rat. Again, (S,S)-37 was the most active agent tested (ID50 0.02 mug/kg iv), and this compound was also potent in blocking cisplatin-induced emesis in both the ferret and the dog. Computer modeling studies were performed, and previously reported 5-HT3 receptor antagonist pharmacophore models were refined to include a key lipophilic binding domain.
    DOI:
    10.1021/jm00070a008
  • 作为产物:
    描述:
    邻甲苯氨基甲酸叔丁酯仲丁基锂 、 sodium hydride 、 三氟乙酸 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 、 paraffin 为溶剂, 反应 48.83h, 生成 7,8,9,10-Tetrahydro-6H-azepino<1,2-a>indole
    参考文献:
    名称:
    Preparation of Indoles and Oxindoles fromN-(tert-Butoxycarbonyl)-2-alkylanilines
    摘要:
    使用双锂化的N-(叔丁氧羰基)苯胺1与二甲基甲酰胺或二氧化碳反应,可得到中间体3和5,它们分别容易转化为N-(叔丁氧羰基)吲哚4和氧化吲哚(吲哚-2(3H)-酮,7)。双锂化的1与N-甲氧基-N-甲基酰胺缩合得到酮9,这些酮在三氟乙酸处理下环化,根据反应时间的不同,形成2-取代的1-(叔丁氧羰基)吲哚10或2-取代的吲哚11。这一通用方法已被应用于高效合成1,2-烷基桥联吲哚12、1,3,4,5-四氢苯[c,d]吲哚(16)、2a,3,4,5-四氢苯[c,d]吲哚-2(1H)-酮(18)以及1-(叔丁氧羰基)-1H-吡咯并[2,3-b]吡啶(21)。
    DOI:
    10.1055/s-1991-26597
点击查看最新优质反应信息

文献信息

  • A novel synthetic use of trialkyl(indol-2-yl)borate for a “one-pot” synthesis of [a]-annelated indoles
    作者:Minoru Ishikura、Masanao Terashima
    DOI:10.1016/s0040-4039(00)61792-6
    日期:1992.11
    A novel one-pot procedure for [a]-annelated indole via cyclic trialkyl(indol-2-yl)borate is described.
    描述了通过环状三烷基(吲哚-2-基)硼酸酯用于[ α ]-退火的吲哚的新颖的一锅法。
  • 4-\x9b3-indolyl!-1H-pyrrolone
    申请人:Hoffmann-La Roche Inc.
    公开号:US05721245A1
    公开(公告)日:1998-02-24
    A compound of the formula ##STR1## wherein R is hydrogen or hydroxy, R.sup.1 and R.sup.2 taken together are a group of the formula --(CH.sub.2).sub.m -- and R.sup.7 is hydrogen or R.sup.1 and R.sup.7 taken together are a group of the formula --(CH.sub.2).sub.n -- and R.sup.2 is hydrogen; R.sup.3 is an aryl or aromatic heterocyclic group; R.sup.4, R.sup.5 and R.sup.6 each independently are hydrogen, halogen, alkyl, hydroxy, alkoxy, haloalkyl, nitro, amino, acylamino, alkylthio, alkylsulfinyl or alkylsulfonyl; R.sup.8 is a group of the formula --(CH.sub.2).sub.p --R.sup.9 or --(CH.sub.2).sub.q --R.sup.10 ; R.sup.9 is hydrogen, alkylcarbonyl, aminoalkylcarbonyl, cyano, amidino, alkoxycarbonyl, aryloxycarbonyl, alkylsulfonyl, aminocarbonyl or aminothiocarbonyl; R.sup.10 is hydroxy, alkoxy, halogen, amino, monoalkylamino, dialkylamino, trialkylamino, azido, acylamino, alkylsulfonylamino, a 5- or 6-membered saturated nitrogen-containing heterocycle; X and Y are oxygen; Z is CH; m, p and q are, independently, an integer from 0 to 5, and n an integer from 1 to 5, as well as pharmaceutically acceptable salts thereof which are useful in the control of inflammatory, immunological, oncological, bronchopulmonary or cardiovascular disorders.
    公式的化合物,其中R是氢或羟基,R1和R2共同构成组--(CH2)m--,R7是氢或R1和R7共同构成组--(CH2)n--,且R2是氢;R3是一种芳香族或芳香杂环群;R4、R5和R6各自独立地为氢、卤素、烷基、羟基、烷氧基、卤代烷基、硝基、氨基、酰氨基、烷基硫醚、烷基亚磺酰基或烷基磺酰基;R8是组--(CH2)p--R9或--(CH2)q--R10;R9是氢、烷基碳酰基、氨基烷基碳酰基、氰基、脒基、烷氧基碳酰基、芳氧基碳酰基、烷基磺酰基、氨基甲酰基或硫代氨基甲酰基;R10是羟基、烷氧基、卤素、氨基、一烷基胺、二烷基胺、三烷基胺、叠氮基、酰氨基、烷基磺酰氨基、一个5或6成员的饱和含氮杂环;X和Y是氧;Z是CH;m、p和q各自独立地为0到5的整数,n为1到5的整数,以及作为药物可接受的盐,其在控制炎症、免疫、肿瘤、支气管肺或心血管疾病方面是有用的。
  • A Dieckmann/ring expansion approach to tetrahydropyrido- and tetrahydroazepino-[1,2-a]indoles
    作者:Rino A. Bit、Peter D. Davis、Christopher H. Hill、Elizabeth Keech、David R. Vesey
    DOI:10.1016/s0040-4020(01)86471-1
    日期:1991.1
    A general Dieckmann/ring expansion approach to fused [1,2-a]indole systems is reported. This approach has allowed the synthesis of a large variety of substituted systems required for the preparation of a series of potent and selective inhibitors of Protein Kinase C.
    据报道,一般的Dieckmann /环膨胀方法用于稠合的[1,2-a]吲哚体系。这种方法已允许合成制备一系列有效和选择性的蛋白激酶C抑制剂所需的多种取代系统。
  • A one-pot access to cycloalkano[1,2-a]indoles through an intramolecular alkyl migration reaction in indolylborates
    作者:Minoru Ishikura、Wataru Ida、Kazuo Yanada
    DOI:10.1016/j.tet.2005.10.045
    日期:2006.1
    protocol for the preparation of cycloalkano[1,2-a]indoles by way of an intramolecular alkyl migration reaction in cyclic indolylborates is described. NaOMe was found to act as a successful trialkylboryl-protecting group against to the lithiation at the C2 of the indole ring. Treatment of cyclic indolylborates with electrophiles produced cycloalkano-[1,2-a]indoles.
    描述了一种新颖的一锅法,用于通过环状吲哚硼酸酯中的分子内烷基迁移反应制备环烷[1,2- a ]吲哚。发现NaOMe可作为成功的三烷基硼基保护基团来抵抗吲哚环C2上的锂化。用亲电试剂处理环状吲哚硼酸酯产生环烷-[1,2- a ]吲哚。
  • Novel intramolecular radical displacement reactions of 2-indolyl aryl sulfides and sulfoxides
    作者:Stephen Caddick、Karim Aboutayab、Robert I. West
    DOI:10.1039/c39950001353
    日期:——
    A novel radical substitution reaction is described; the reaction involves the intramolecular addition of carbon-centred radicals to aryl sulfoxide and aryl sulfide substituted indoles.
    描述了一种新颖的自由基取代反应。该反应涉及将碳中心自由基分子内加成到芳基亚砜和芳基硫醚取代的吲哚中。
查看更多

同类化合物

环戊二烯并[4,5]氮杂卓并[2,1,7-cd]吡咯里嗪 吡咯并[1,2-a]氮杂-5-酮 六氢-1H-吡咯并[1,2-A]氮杂卓-5(6H)-酮 N,N-二甲基-3-(3-甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)丙-1-胺 9-氟-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 7,8-二氢-5H-吡咯并[1,2-A]氮杂环庚烷-9(6H)-酮 6-叔-丁基3A-乙基八氢吡咯并[2,3-D]氮杂卓-3A,6(2H)-二甲酸基酯 6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮 5H-吡咯并[1,2-a]氮杂卓-7-醇 5,9:7,11-二亚甲基-5H-吡咯并[1,2-a]吖壬英-3-羧酸,6,7,8,9,10,11-六氢-,甲基酯 4-(2-氨基-1H-咪唑-5-基)-2,3-二溴-6,7-二氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1H-咪唑-4-基)-2,3-二溴-4,5,6,7-四氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1,5-二氢-5-氧代-4H-咪唑-4-亚基)-4,5,6,7-四氢-吡咯并[2,3-c]氮杂卓-8(1H)-酮 3-苄基-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 3-(3,9-二甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)-N,N-二甲基丙烷-1-胺 2H,3H-氧杂环丁烷并[3,2-d]吡咯并[1,2-a]氮杂卓 2-溴-6,7-二氢-1h,5h-吡咯并[2,3-c]氮杂烷-4,8-二酮 2,5-已炔二醇 2,3,4,5-四氢-N,N-二甲基-2-(3,4,5-三甲氧基苯甲酰基)-氮杂卓并(3,4-b)吲哚-10(1H)-丙胺 11-氧杂-3,10-二氮杂三环[7.2.1.03,7]十二碳-1,4,6,9-四烯 1,4,5,6,7,8-六氢吡咯并[3,2-b]氮杂卓 1,2,3,4,5,6-六氢氮杂环庚烷[4,3-B]吲哚盐酸盐 1,2,3,4,5,6-六氢-9-甲基氮杂卓并[4,5-b]吲哚 1,2,3,4,5,6-六氢-6-甲基氮杂革[4,5-b]吲哚盐酸盐 1,2,3,4,5,6-六氢-3-甲基氮杂卓并[4,5-b]吲哚 (1R*,2E,11S*)-2-(cyclohexylmethylene)-1-(phenylsilyl)methyloctahydropyrrolo[1,2-a]azepine (R)-2-(6,7,8,9-tetrahydro-5H-pyrrolo[1,2-a]azepin-9-yl)-acetaldehyde curvulamine (3aR,8aS)-tert-butyl octahydropyrrolo[3,4-d]azepine-2(1H)-carboxylate hydrochloride tert-butyl 6-(2-amino-2-oxoethyl)-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate 3-benzoyl-10-bromo-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-(tert-butyloxycarbonyl)-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethylazepino[4,5-b]indole 1,2,3,4,5,6-hexahydro-3-dimethylaminoethyl-5-hydroxymethyl-6-methylazepino[4,5-b]indole (Z)-2,3,9,9a-tetrahydro-6,6-dimethyl-9-methylene-8-vinyl-1H-pyrrolo[1,2-a]azepin-5(6H)-one 2,3,4,5,6,7-hexahydro-1H-3a,8,13,13b-tetraazabenzo[b]cyclopenta[1,2,3-jk]fluorene 2,3,4,5,6,7-hexahydro-1H-3a,8,11,11b-tetraazacyclohepta[1,2,3-jk]fluorene 1-Benzyloxy-2-methoxy-7,8,9,10-tetrahydro-6H-azepino<1,2-a>indole-11-carbaldehyde 3-benzoyl-10-(2-propoxyphenyl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 2-phenyl-2,4,5,6-tetrahydro-1H-6-azabenzo[a]cyclohepta[cd]azulen-1-one 2-carbetoxy-3-(N,N-dimethyl)aminomethyleneamino-8-oxo-8H-4,5,6,7-tetrahydropyrrolo<2,3-c>azepine 3-benzoyl-10-[2-(trifluoromethyl)phenyl]-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 3-benzoyl-10-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole 6-[2-(4-fluorophenyl)ethyl]-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 5-(2-hydroxy-3-morpholin-4-yl-propyl)-3-methyl-4-oxo-1,4,5,6,7,8-hexahydro-pyrrolo[3,2-c]azepine-2-carbaldehyde 6-(2-phenylethyl)-3,4,5,6-tetrahydroazepino[4,3-b]indol-1(2H)-one 11-(tert-butyldimethylsilyloxy)-1-trimethylsilyl-3a,4,11,12-tetrahydro-3H-cyclopenta[5,6]azepine[1,2-a]indole-2-one tert-butyl 8,9-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl 9,10-dichloro-6-[2-(2,3-dimethylanilino)-2-oxoethyl]-1,4,5,6-tetrahydroazepino[4,5-b]indole-3(2H)-carboxylate tert-butyl (1R,4S)-1-(benzylcarbamoyl)-3-oxo-2-((S)-1-phenylethyl)-1,2,3,4,5,10-hexahydroazepino[3,4-b]indol-4-ylcarbamate